Treatment of stage i NSCLC in elderly patients: A population-based matched-pair comparison of stereotactic radiotherapy versus surgery

Radiotherapy and Oncology

Volumn 101, Issue 2, 2011, Pages 240-244

  Palma, David ^a,b   Visser, Otto ^c   Lagerwaard, Frank J ^a   Belderbos, Jose ^d   Slotman, Ben ^a   Senan, Suresh ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LONDON REGIONAL CANCER PROGRAM   (Canada)

^c Integraal Kankercentrum Amsterdam   (Netherlands)

^d NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Geriatric oncology; Lung cancer; Stereotactic radiotherapy; Surgery

Indexed keywords

AGED; ARTICLE; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER STAGING; CASE CONTROL STUDY; COMORBIDITY; CONTROLLED STUDY; ELDERLY CARE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM STAGING; NETHERLANDS; PNEUMONECTOMY; RADIOSURGERY; RADIOTHERAPY DOSAGE; REGISTRIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 81755161522     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2011.06.029     Document Type: Article

References (41)

1. B.K. Edwards, H.L. Howe, and L.A. Ries Annual report to the nation on the status of cancer, 1973-1999. Featuring implications of age and aging on US cancer burden Cancer 94 2002 2766 2792 (Pubitemid 34478095)
2. T.K. Owonikoko, C.C. Ragin, and C.P. Belani Lung cancer in elderly patients: an analysis of the surveillance, epidemiology, and end results database J Clin Oncol 25 2007 5570 5577
3. M.W.J.M. Wouters, S. Siesling, and M.L. Jansen-Landheer Variation in treatment and outcome in patients with non-small cell lung cancer by region, hospital type and volume in the Netherlands Eur J Surg Oncol 36 2010 S83 92
4. F.C. Detterbeck, and C.J. Gibson Turning gray: the natural history of lung cancer over time J Thorac Oncol 3 2008 781 792
5. R.A. Audisio, A.P. Zbar, and M.T. Jaklitsch Surgical management of oncogeriatric patients J Clin Oncol 25 2007 1924 1929 (Pubitemid 46854427)
6. A. Chi, Z. Liao, N.P. Nguyen, J. Xu, B. Stea, and R. Komaki Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: clinical implications Radiother Oncol 94 2010 1 11
7. P. Baumann, J. Nyman, and M. Hoyer Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer - a first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study Radiother Oncol 88 2008 359 367
8. S. Senan, C. Gundy, C.J. Haasbeek, B.J. Slotman, N.K. Aaronson, and F. Lagerwaard Health-related quality of life (HRQOL) after stereotactic body radiotherapy (SBRT) for stage I non-small cell lung cancer (NSCLC) Clin Oncol (Meeting Abstracts) 2010 28 2010 7079
9. T. Schulte, B. Schniewind, J. Walter, P. Dohrmann, T. Kuchler, and R. Kurdow Age-related impairment of quality of life after lung resection for non-small cell lung cancer Lung cancer 68 2010 115 120
10. C.J. Haasbeek, F.J. Lagerwaard, M.E. Antonisse, B.J. Slotman, and S. Senan Stage I nonsmall cell lung cancer in patients aged > or =75 years: outcomes after stereotactic radiotherapy Cancer 116 2010 406 414
11. N.P. Nguyen, L. Garland, J. Welsh, R. Hamilton, D. Cohen, and V. Vinh-Hung Can stereotactic fractionated radiation therapy become the standard of care for early stage non-small cell lung carcinoma Cancer Treat Rev 34 2008 719 727
12. J.P.C. Grutters, A.G.H. Kessels, M. Pijls-Johannesma, D. De Ruysscher, M.A. Joore, and P. Lambin Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: a meta-analysis Radiother Oncol 95 2010 32 40
13. D. Palma, O. Visser, F.J. Lagerwaard, J. Belderbos, B.J. Slotman, and S. Senan Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: a population-based time-trend analysis J Clin Oncol 28 2010 5153 5159
14. National Comprehensive Cancer Network Clinical Practice Guideline: Non-Small Cell Lung Cancer 2010. < www.nccn.org > Accessed: June 1, 2011.
15. C.W. Hurkmans, J.P. Cuijpers, and F.J. Lagerwaard Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study Radiat Oncol 4 2009 1
16. International Randomized Study to Compare CyberKnife Stereotactic Radiotherapy With Surgical Resection In Stage I Non-small Cell Lung Cancer (STARS). < http://www.clinicaltrials.gov/ct2/show/NCT00840749 >. Accessed: May 30, 2011.
17. T.D. Crabtree, C.E. Denlinger, and B.F. Meyers Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer J Thorac Cardiovasc Surg 140 2010 377 386
18. G.A.C. Sanden, J.W.W. Coebergh, L.J. Schouten, O. Visser, and F.E. Leeuwen Cancer incidence in the Netherlands in 1989 and 1990: first results of the nationwide Netherlands cancer registry Eur J Cancer 31 1995 1822 1829
19. O. Visser, and F.E. van Leeuwen Stage-specific survival of epithelial cancers in North-Holland/Flevoland, The Netherlands Eur J Cancer 41 2005 2321 2330 (Pubitemid 41415609)
20. D.B. Rubin Matching to remove bias in observational studies Biometrics 29 1975 159 183
21. M.A. de Graaf, K.J. Jager, C. Zoccali, and F.W. Dekker Matching, an appealing method to avoid confounding Nephron Clin Pract 118 2011 c315 c318
22. F.J. Lagerwaard, C.J. Haasbeek, E.F. Smit, B.J. Slotman, and S. Senan Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer Int J Radiat Oncol Biol Phys 70 2008 685 692
23. H. Onishi, H. Shirato, and Y. Nagata Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study J Thorac Oncol 2 2007 S94 100
24. B.J. McNeil, R. Weichselbaum, and S.G. Pauker Fallacy of the five-year survival in lung cancer N Engl J Med 299 1978 1397 1401 (Pubitemid 9092483)
25. T. Inoue, S. Shimizu, and R. Onimaru Clinical outcomes of stereotactic body radiotherapy for small lung lesions clinically diagnosed as primary lung cancer on radiologic examination Int J Radiat Oncol Biol Phys 75 2009 683 687
26. G.J. Herder, T.H. van, and R.P. Golding Clinical prediction model to characterize pulmonary nodules: validation and added value of 18F-fluorodeoxyglucose positron emission tomography Chest 128 2005 2490 2496 (Pubitemid 41507599)
27. G.J.M. Herder, H. Kramer, and O.S. Hoekstra Traditional versus up-front [18F] fluorodeoxyglucose-positron emission tomography staging of non-small-cell lung cancer: a dutch cooperative randomized study J Clin Oncol 24 2006 1800 1806 (Pubitemid 46638976)
28. H. van Tinteren, O.S. Hoekstra, and E.F. Smit Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial Lancet 359 2002 1388 1393
29. E. Finlayson, Z. Fan, and J.D. Birkmeyer Outcomes in octogenarians undergoing high-risk cancer operation: a national study J Am Coll Surg 205 2007 729 734 (Pubitemid 350116627)
30. Y. Nagata, M. Hiraoka, and T. Shibata A phase II trial of stereotactic body radiation therapy for operable T1N0M0 non-small cell lung cancer: Japan clinical oncology group (JCOG0403) Int J Radiat Oncol Biol Phys 78 2010 S27 S28
31. Onishi H, Shirato H, Nagata Y, et al. Stereotactic Body Radiotherapy (SBRT) for Operable Stage I Non-Small-Cell Lung Cancer: Can SBRT Be Comparable to Surgery? Int J Radiat Oncol Biol Phys. 2010 Jul 15 [epub ahead of print].
32. I.S. Grills, V.S. Mangona, and R. Welsh Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer J Clin Oncol 28 2010 928 935
33. Palma D, Lagerwaard F, Rodrigues G, Haasbeek CJ, Senan S. Curative treatment of stage I non-small cell lung cancer in patients with severe COPD: stereotactic radiotherapy outcomes and systematic review. Int J Radiat Oncol Biol Phys. 2011 June 1 [epub ahead of print].
34. Louie AV, Rodrigues G, Hannouf M, et al. Stereotactic body radiotherapy versus surgery for stage I NSCLC: a Markov model-based decision analysis. Int J Radiat Oncol Biol Phys. 2010 Oct 5 [epub ahead of print].
35. A.G. Little, V.W. Rusch, and J.A. Bonner Patterns of surgical care of lung cancer patients Ann Thorac Surg 80 2005 2051 2056 (Pubitemid 41718027)
36. P.B. Bach, L.D. Cramer, D. Schrag, R.J. Downey, S.E. Gelfand, and C.B. Begg The influence of hospital volume on survival after resection for lung cancer N Engl J Med 345 2001 181 188 (Pubitemid 32662128)
37. M.F. Jimenez, A. van Baardwijk, and H.J.W.L. Aerts Effectiveness of surgery and individualized high-dose hyperfractionated accelerated radiotherapy on survival in clinical stage I non-small cell lung cancer. A propensity score matched analysis Radiother Oncol 97 2010 413 417
38. N. Kopek, M. Paludan, J. Petersen, A.T. Hansen, C. Grau, and M. Høyer Co-morbidity index predicts for mortality after stereotactic body radiotherapy for medically inoperable early-stage non-small cell lung cancer Radiother Oncol 93 2009 402 407
39. B.M. Stiles, E.L. Servais, P.C. Lee, J.L. Port, S. Paul, and N.K. Altorki Clinical stage IA non-small cell lung cancer determined by computed tomography and positron emission tomography is frequently not pathologic IA non-small cell lung cancer: the problem of understaging J Thorac Cardiovasc Surg 137 2009 13 19
40. A Randomized Clinical Trial of Either Surgery or Stereotactic Radiotherapy for Early Stage (IA) Lung Cancer (ROSEL), 2008 < http://www.clinicaltrials.gov/ct2/show/NCT00687986 >. Accessed June 1, 2011.
41. Levels of Evidence for Adult and Pediatric Cancer Treatment Studies (PDQr), National Cancer Institute 2009. < http://www.cancer.gov/cancertopics/ pdq/levels-evidence-adult-treatment/HealthProfessional/page1 >. Accessed: June 1, 2011.